Beacon Financial Advisory’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$224K Buy
+1,503
New +$211K 0.04% 399
2025
Q2
– Sell
-2,249
Closed -$252K – 357
2025
Q1
$252K Buy
2,249
+15
+0.7% +$1.55K 0.08% 276
2024
Q4
$206K Buy
+2,234
New +$201K 0.07% 284

Other funds holding GILD

Beacon Financial Advisory's GILD Position: Q3 2026 in Review

Beacon Financial Advisory opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,503 shares worth $224K. The stake represents 0.04% of the portfolio and ranks #399 among its holdings. This is a return to the name: Beacon Financial Advisory previously reported a position in GILD as recently as Q1 2025.

Beacon Financial Advisory first reported a position in GILD in Q4 2024 and has held it in 3 quarters since. The position peaked at $252K in Q1 2025. 336 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Beacon Financial Advisory held 1,503 shares of Gilead Sciences worth $224K as of Q3 2026.
  • Gilead Sciences was a new Beacon Financial Advisory position in Q3 2026.
  • Gilead Sciences made up 0.04% of Beacon Financial Advisory's portfolio in Q3 2026, its #399 holding.
  • Beacon Financial Advisory first reported a position in Gilead Sciences in Q4 2024 and has held it in 3 quarters since.
  • Beacon Financial Advisory's Gilead Sciences position peaked at $252K in Q1 2025.
  • 336 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Beacon Financial Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.